Advancing CAR-T Immunotherapy: The Growing Adoptive Cell Therapy Market
The field of cancer immunotherapy has been revolutionized by the development of chimeric antigen receptor (CAR) T cell therapy, offering a personalized and highly effective treatment option for patients with hematologic malignancies. CAR-T immunotherapy involves engineering a patient's own T cells to recognize and attack cancer cells, providing a targeted approach with durable responses....
0 Commenti 0 condivisioni 91 Views 0 Anteprima